Navigation Links
50-year cholera mystery solved
Date:5/29/2012

AUSTIN, Texas For 50 years scientists have been unsure how the bacteria that gives humans cholera manages to resist one of our basic innate immune responses. That mystery has now been solved, thanks to research from biologists at The University of Texas at Austin.

The answers may help clear the way for a new class of antibiotics that don't directly shut down pathogenic bacteria such as V. cholerae, but instead disable their defenses so that our own immune systems can do the killing.

Every year cholera afflicts millions of people and kills hundreds of thousands, predominantly in the developing world. The infection causes profuse diarrhea and vomiting. Death comes from severe dehydration.

"If you understand the mechanism, the bacterial target, you're more likely to be able to design an effective antibiotic," says Stephen Trent, associate professor of molecular genetics and microbiology and lead researcher on the study.

The bacterium's defense, which was unmasked this month in the Proceedings of the National Academy of Sciences, involves attaching one or two small amino acids to the large molecules, known as endotoxins, that cover about 75 percent of the bacterium's outer surface.

"It's like it's hardening its armor so that our defenses can't get through," says Trent.

Trent says these tiny amino acids simply change the electrical charge on that outer surface of the bacteria. It goes from negative to neutral.

That's important because the molecules we rely on to fight off such bacteria, which are called cationic antimicrobial peptides (CAMPs), are positively charged. They can bind to the negatively charged surface of bacteria, and when they do so, they insert themselves into the bacterial membrane and form a pore. Water then flows through the pore into the bacterium and pops it open from the inside, killing the harmful bacteria.

It's an effective defense, which is why these CAMPs are ubiquitous in nature (as well as one of the main ingredients in over-the-counter antibacterial ointments such as Neosporin).

However, when the positively charged CAMPs come up against the neutral V. cholerae bacteria, they can't bind. They bounce away, and we're left vulnerable.

V. cholerae can then invade our intestines and turn them into a kind of factory for producing more cholera, in the process rendering us incapable of holding onto fluids or extracting sufficient nutrients from what we eat and drink.

"It pretty much takes over your normal flora," says Trent.

Trent says that scientists have known for some time that the strain of V. cholerae responsible for the current pandemic in Haiti and elsewhere is resistant to these CAMPs. It's that resistance that is likely responsible, in part, for why the current strain displaced the strain that was responsible for previous pandemics.

"It's orders of magnitude more resistant," says Trent.

Now that Trent and his colleagues understand the mechanism behind this resistance, they hope to use that knowledge to help develop antibiotics that can disable the defense, perhaps by preventing the cholera bacteria from hardening their armor. If that happened, our CAMPs could do the rest of the work.

Trent says the benefits of such an antibiotic would be considerable. It might be effective against not just cholera but a range of dangerous bacteria that use similar defenses. And because it disarms but doesn't kill the bacteria outright, as traditional antibiotics do, it might take longer for the bacteria to mutate and evolve resistance in response to it.

"If we can go directly at these amino acids that it uses to protect against us, and then allow our own innate immune system to kill the bug, there could be less selection pressure," he says.

Trent's lab is now screening for compounds that would do precisely that.


'/>"/>

Contact: Stephen Trent
strent@mail.utexas.edu
512-232-8371
University of Texas at Austin
Source:Eurekalert

Related medicine news :

1. Novel mouse model for autism yields clues to a 50-year-old mystery
2. From cholera to blindness, experts present cutting-edge research at international meeting
3. Cholera and vaccine experts urge United States to stockpile vaccine
4. Experts urge US to create emergency cholera vaccine stockpile for humanitarian use
5. Special sugar, nanoparticles combine to detect cholera toxin
6. Toward a fast, simple test for detecting cholera rampaging in 40 countries
7. Haiti Cholera Epidemic Could Sicken 779,000 This Year
8. UF researchers suggest cholera vaccination strategies for Zimbabwe
9. IVI announces the prequalification of innovative cholera vaccine by the World Health Organization
10. Choleras nano-dagger
11. Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Fla. (PRWEB) , ... February 20, 2017 , ... Scrubbing ... Cancer Center in Houston, Dr. Christopher Pezzi remembers the excitement of the surgeon training ... believe they pay us to do this? Don’t tell anyone, but I would do ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... industries, announced Biscom Document Router (BDR), the first IoT device from Biscom designed ... and imaging. Biscom will debut BDR at HIMSS17 and will be ...
(Date:2/20/2017)... ... February 20, 2017 , ... Johns Hopkins All Children's Hospital celebrated a ... out ceremony on Friday marked the halfway point of construction and lifting of the ... 2018, will serve as a center for innovation aimed at finding new discoveries and ...
(Date:2/19/2017)... ... February 19, 2017 , ... Braun Industries will be participating as an ... event will take place February 23-25, 2017 at the Calvin L. Rampton Salt Palace ... with three new ambulances on display. , “JEMS is a leader ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... disruptive innovation in the industry, according to the recent NEJM Catalyst Insights Report ... surveys of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... , Feb. 20, 2017 Systems ... that creates detailed images of the organs and tissues ... field and radio waves. The technique does not use ... of brain function or growth of cancer. MRI is ... neurology, cardiology, oncology, musculoskeletal, and orthopedics. Hence, MRI helps ...
(Date:2/20/2017)... -- Report analyzes the worldwide markets for Infusion ... Ambulatory Infusion Pumps, Enteral Feeding Pumps, Insulin Infusion ... and Syringe Infusion Pumps. The report provides separate ... Asia-Pacific, Latin America, and Rest of World. ... Annual estimates and forecasts are provided for ...
(Date:2/20/2017)... This report analyzes the worldwide markets for Human ... comprehensive analytics for the US, Canada , ... Asia-Pacific , and Rest of World. ... Annual estimates and forecasts are provided for the period ... for these markets. Market data and analytics are derived from ...
Breaking Medicine Technology: